Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CISD1 | Q9NZ45 | 4/20 | 0.67 |
| ▸ | MAOA | P21397 | 2/20 | 0.67 |
| ▸ | MAOB | P27338 | 1/20 | 0.67 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | DUSP22 | Q9NRW4 | 6/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.53 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27931454 | 0.83 | CISD1 (0.53) | CISD1MAOAMAOBPKMDUSP22 | |
| SCHEMBL11778921 | 0.80 | CISD1 (1.00) | CISD1MAOAMAOBMAPTKMT2A | |
| SCHEMBL12333891 | 0.80 | CISD1 (1.00) | CISD1MAOAMAOBMAPTKMT2A | |
| SCHEMBL10801539 | 0.80 | CISD1 (1.00) | CISD1MAOAMAOBMAPTKMT2A | |
| SCHEMBL6784135 | 0.80 | CISD1 (0.67) | CISD1MAOAMAOBPKMDUSP22 | |
| SCHEMBL6784131 | 0.80 | CISD1 (0.67) | CISD1MAOAMAOBPKMDUSP22 | |
| SCHEMBL9917038 | 0.79 | DUSP22 (0.77) | CISD1MAOAMAOBDUSP22MAPT | |
| SCHEMBL12123516 | 0.79 | DUSP22 (0.77) | CISD1MAOAMAOBDUSP22MAPT | |
| SCHEMBL10035996 | 0.79 | DUSP22 (0.77) | CISD1MAOAMAOBDUSP22MAPT | |
| SCHEMBL9293059 | 0.78 | CRHBP (0.59) | PKMDUSP22MAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590127-B2 | Split photoactive yellow protein complementation system and uses thereof | PARIS SCIENCES ET LETTRES (FR) | 2026-03-31 | — | — | US | claimed |
| US-20220169682-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | PARIS SCIENCES ET LETTRES (FR) | 2022-06-02 | — | — | US | claimed |
| EP-3947355-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | Paris Sciences et Lettres (FR) | 2022-02-09 | — | — | EP | claimed |
| WO-2020201538-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | PARIS SCIENCES ET LETTRES – QUARTIER LATIN (FR) | 2020-10-08 | — | — | WO | claimed |
| EP-3719007-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | Paris Sciences et Lettres - Quartier Latin (FR) | 2020-10-07 | — | — | EP | claimed |
| EP-4747390-A2 | PROTEIN EXPRESSION REAGENTS | Nuclera Ltd (GB) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026104714-A1 | PROTEIN EXPRESSION SYSTEMS | NUCLERA LTD (GB) | 2026-05-21 | — | — | WO | disclosed |
| US-12590127-B2 | Split photoactive yellow protein complementation system and uses thereof | PARIS SCIENCES ET LETTRES (FR) | 2026-03-31 | — | — | US | disclosed |
| US-12590127-B2 | Split photoactive yellow protein complementation system and uses thereof | PARIS SCIENCES ET LETTRES (FR) | 2026-03-31 | — | — | US | disclosed |
| EP-4713683-A1 | A METHOD TO HOMOGENIZE THE CONCENTRATION OF BEADS ACROSS MULTIPLE LIQUID VOLUMES | Nuclera Ltd (GB) | 2026-03-25 | — | — | EP | disclosed |
| US-20260072018-A1 | PROTEIN BINDING ASSAYS | NUCLERA LTD (GB) | 2026-03-12 | — | — | US | disclosed |
| EP-4689663-A1 | PROTEIN EXPRESSION SYSTEMS | Nuclera Ltd (GB) | 2026-02-11 | — | — | EP | disclosed |
| WO-2022038353-A1 | MONITORING OF IN VITRO PROTEIN SYNTHESIS | NUCLERA NUCLEICS LTD (GB) | 2022-02-24 | — | — | WO | disclosed |
| EP-3947355-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | Paris Sciences et Lettres (FR) | 2022-02-09 | — | — | EP | disclosed |
| EP-3947355-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | Paris Sciences et Lettres (FR) | 2022-02-09 | — | — | EP | disclosed |
| US-20210396762-A1 | METHODS FOR PEPTIDE ANALYSIS EMPLOYING MULTI-COMPONENT DETECTION AGENT AND RELATED KITS | Encodia, Inc. (US) | 2021-12-23 | — | — | US | disclosed |
| WO-2020201538-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | PARIS SCIENCES ET LETTRES – QUARTIER LATIN (FR) | 2020-10-08 | — | — | WO | disclosed |
| WO-2020201538-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | PARIS SCIENCES ET LETTRES – QUARTIER LATIN (FR) | 2020-10-08 | — | — | WO | disclosed |
| EP-3719007-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | Paris Sciences et Lettres - Quartier Latin (FR) | 2020-10-07 | — | — | EP | disclosed |
| EP-3719007-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | Paris Sciences et Lettres - Quartier Latin (FR) | 2020-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169682-A1 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | BLVRB, IK, HBG2 | CISD1 720/4885MAOA 2874/4885MAOB 1565/4885 |
| US-20260072018-A1 | PROTEIN BINDING ASSAYS | EBPL, CYFIP1, YIPF5 | CISD1 136/4885MAOA 4581/4885MAOB 4471/4885 |
| US-12590127-B2 | Split photoactive yellow protein complementation system and uses thereof | BLVRB, HBG2, Q6ZSR9 | CISD1 758/4885MAOA 2068/4885MAOB 856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.